Based on this beneficial role for alternatively activated Kupffer cells in metabolic syndrome conditions, controlling PPARβ/δ activity in these cells may contribute to delaying NAFLD progression. This evidence concerns the gene PPARD and metabolic dysfunction-associated steatotic liver disease.